AnalystsChristopher MaraiChristopher Marai's Stock Forecasts
AnalystsChristopher Marai
Analyst Ranking
Bottom 11%
#4089 out of 4563 analysts
Average Return
-2.5%
Win Rate
48%15 out of 31
Risk vs Reward
Poor
Good
Christopher Marai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Protagonist Therapeutics IncPTGX | +101.71% | $14.63 | $29.51 | 2020-05-11 - 2021-05-11 | Strong Buy |
Solid Biosciences IncSLDB | +88.05% | $37.65 | $70.80 | 2020-05-08 - 2021-05-07 | Strong Buy |
Solid Biosciences IncSLDB | +84.61% | $59.48 | $109.80 | 2019-12-18 - 2020-12-18 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +77.08% | $4.80 | $8.50 | 2018-12-17 - 2019-12-17 | Strong Buy |
Solid Biosciences IncSLDB | +75.96% | $62.40 | $109.80 | 2019-12-19 - 2020-12-18 | Strong Buy |
Christopher Marai Analyst Color
Get additional color on Christopher Marai's coverage of popular stocks
Christopher Marai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Strong Buy | $960.00 | N/A | Maintains | 4 years ago |
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $33.00 | N/A | Maintains | 4 years ago |
Solid Biosciences IncSLDB | 5 | Strong Buy | $90.00 | N/A | Maintains | 4 years ago |
Deciphera Pharmaceuticals IncDCPH | 2 | Hold | $60.00 | N/A | Downgrades | 4 years ago |
Stealth Biotherapeutics CorpMITO | 1 | Strong Buy | $10.00 | N/A | Maintains | 4 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $16.00 | N/A | Maintains | 4 years ago |
Biogen IncBIIB | 1 | Strong Buy | $392.00 | N/A | Maintains | 4 years ago |
Beyondspring IncBYSI | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 4 years ago |
Kadmon Holdings IncKDMN | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Sarepta Therapeutics IncSRPT | 2 | Strong Buy | $230.00 | N/A | Maintains | 5 years ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $12.00 | N/A | Maintains | 5 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Sell | $73.00 | N/A | Maintains | 6 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $109.00 | N/A | Maintains | 6 years ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Buy | $19.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Strong Buy | $156.00 | N/A | Maintains | 6 years ago |
Five Prime Therapeutics IncFPRX | 2 | Strong Buy | $25.00 | N/A | Maintains | 6 years ago |
Cellectis SaCLLS | 1 | Strong Buy | $43.00 | N/A | Maintains | 7 years ago |
Avexis IncAVXS | 1 | Sell | $52.00 | N/A | Initiates Coverage On | 7 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.